Bionor Pharma ASA engages in the development of soy technology for the treatment and prevention of life-style related diseases. It offers Nutrilett and NutriPro, which are health care products for weight management; and Abacor, a patented composition of isolated soy protein, soy isoflavones, cotyledon soy fiber, and phospholipids used for the reduction of cholesterol. The company also provides Nutri5, which is used for the treatment of menopausal and pre-menstrual symptoms; and NutriBar and Nutri Femme nutrition products. It has operations in the Nordic countries, Russia, and the Commonwealth of Independent States. The company was formerly known as Nutri Pharma ASA and changed its name to Bionor Pharma ASA on June 14, 2010. Bionor Pharma ASA was founded in 1993 and is based in Oslo, Norway.